Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 117 participants.
Also called NCT02390102
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 117 participants
- Registry
-
NCT02390102
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02390102. Randomized; quadruple masking; primary purpose treatment. Start 2012-06 (actual); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement
- Acronym
- EPICURE
- Condition
- Anemia
- Condition
- Aortic Stenosis
- Intervention (Drug)
- Erythropoietin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Record details
- Record id
cardio:ct-nct02390102- Content hash
8fb466f1675da2e1007cb51f7da5a8fc99642d678114363267aed4de72cf4515